WEST PHARMACEUTICAL SERVICES, INC. Other Restructuring Costs
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Restructuring Costs of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherRestructuringCosts · last filed 2025-02-18
- WEST PHARMACEUTICAL SERVICES, INC. other restructuring costs for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other restructuring costs for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other restructuring costs for the quarter ending 2019-12-31 was $500.00K, a 61.54% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other restructuring costs for the quarter ending 2019-09-30 was $1.10M, a 57.14% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other restructuring costs for fiscal 2024 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. other restructuring costs for fiscal 2023 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. other restructuring costs for fiscal 2022 was -$200.00K, a 112.50% decline from fiscal 2021.
- WEST PHARMACEUTICAL SERVICES, INC. other restructuring costs for fiscal 2021 was $1.60M.
| Period end | Other Restructuring Costs 3 month | Other Restructuring Costs 6 month | Other Restructuring Costs 9 month | Other Restructuring Costs 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2022-12-31 | -$200.00K 10-K · filed 2025-02-18 | |||
| 2021-12-31 | $1.60M 10-K · filed 2024-02-20 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $0.00 derived: sum of 2 quarters · filed 2023-02-21 | $0.00 10-K · filed 2023-02-21 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-10-23 | $0.00 10-Q · filed 2020-10-23 | ||
| 2019-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $1.60M derived: sum of 2 quarters · filed 2022-02-22 | $1.70M derived: sum of 3 quarters · filed 2022-02-22 | $2.00M 10-K · filed 2022-02-22 |
| 2019-09-30 | $1.10M 10-Q · filed 2020-10-23 | $1.20M derived: sum of 2 quarters · filed 2020-10-23 | $1.50M 10-Q · filed 2020-10-23 | $2.80M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $100.00K 10-Q · filed 2019-07-29 | $400.00K 10-Q · filed 2019-07-29 | $1.70M derived: sum of 3 quarters · filed 2021-02-23 | $2.40M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $300.00K 10-Q · filed 2019-05-08 | $1.60M derived: sum of 2 quarters · filed 2021-02-23 | $2.30M derived: sum of 3 quarters · filed 2021-02-23 | $2.90M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $2.00M derived: sum of 2 quarters · filed 2021-02-23 | $2.60M derived: sum of 3 quarters · filed 2021-02-23 | $3.80M 10-K · filed 2021-02-23 |
| 2018-09-30 | $700.00K 10-Q · filed 2018-10-30 | $1.30M derived: sum of 2 quarters · filed 2019-07-29 | $2.50M 10-Q · filed 2018-10-30 | $2.50M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $600.00K 10-Q · filed 2019-07-29 | $1.80M 10-Q · filed 2019-07-29 | $1.80M derived: sum of 3 quarters · filed 2020-02-24 | $1.80M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $1.20M 10-Q · filed 2019-05-08 | $1.20M derived: sum of 2 quarters · filed 2020-02-24 | $1.20M derived: sum of 3 quarters · filed 2020-02-24 | $1.20M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 10-K · filed 2020-02-24 |
| 2017-09-30 | $0.00 10-Q · filed 2018-10-30 | $0.00 derived: sum of 2 quarters · filed 2018-10-30 | $0.00 10-Q · filed 2018-10-30 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-07-31 | $0.00 10-Q · filed 2018-07-31 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $200.00K 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $0.00 derived: sum of 2 quarters · filed 2014-02-27 | $0.00 derived: sum of 3 quarters · filed 2014-02-27 | $0.00 10-K · filed 2014-02-27 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-04 | $0.00 derived: sum of 2 quarters · filed 2013-11-04 | $0.00 10-Q · filed 2013-11-04 | $200.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-05 | $0.00 10-Q · filed 2013-08-05 | $200.00K derived: sum of 3 quarters · filed 2014-02-27 | $400.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-06 | $200.00K derived: sum of 2 quarters · filed 2014-02-27 | $400.00K derived: sum of 3 quarters · filed 2014-02-27 | $600.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $400.00K derived: sum of 2 quarters · filed 2014-02-27 | $600.00K derived: sum of 3 quarters · filed 2014-02-27 | $900.00K 10-K · filed 2014-02-27 |
| 2012-09-30 | $200.00K 10-Q · filed 2013-11-04 | $400.00K derived: sum of 2 quarters · filed 2013-11-04 | $700.00K 10-Q · filed 2013-11-04 | $1.80M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $200.00K 10-Q · filed 2013-08-05 | $500.00K 10-Q · filed 2013-08-05 | $1.60M derived: sum of 3 quarters · filed 2014-02-27 | $2.60M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $200.00K 10-Q · filed 2013-05-06 | $1.40M derived: sum of 2 quarters · filed 2014-02-27 | $2.40M derived: sum of 3 quarters · filed 2014-02-27 | $3.00M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $2.20M derived: sum of 2 quarters · filed 2014-02-27 | $2.80M derived: sum of 3 quarters · filed 2014-02-27 | $3.00M 10-K · filed 2014-02-27 |
| 2011-09-30 | $1.00M 10-Q · filed 2012-11-05 | $1.60M derived: sum of 2 quarters · filed 2012-11-05 | $1.80M 10-Q · filed 2012-11-05 | $1.80M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $600.00K 10-Q · filed 2012-08-06 | $800.00K 10-Q · filed 2012-08-06 | $800.00K derived: sum of 3 quarters · filed 2013-02-27 | $800.00K derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $200.00K 10-Q · filed 2012-05-04 | $200.00K derived: sum of 2 quarters · filed 2013-02-27 | $200.00K derived: sum of 3 quarters · filed 2013-02-27 | $300.00K derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $0.00 derived: sum of 2 quarters · filed 2013-02-27 | $100.00K derived: sum of 3 quarters · filed 2013-02-27 | $200.00K 10-K · filed 2013-02-27 |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-07 | $100.00K derived: sum of 2 quarters · filed 2011-11-07 | $200.00K 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $100.00K 10-Q/A · filed 2011-08-08 | $200.00K 10-Q/A · filed 2011-08-08 | ||
| 2009-12-31 | $400.00K 10-K/A · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |